4//SEC Filing
CROWLEY Richard 4
Accession 0001181431-11-026542
CIK 0000722104other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 1:08 PM ET
Size
7.3 KB
Accession
0001181431-11-026542
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Award
Common Stock, $.01 par value per share
2011-04-30$11.62/sh−100,000$1,162,000→ 100,000 total - Award
Option to Purchase Common Stock, $.01 par value
2011-04-30$11.62/sh−50,000$581,000→ 50,000 totalExercise: $11.62From: 2012-04-30Exp: 2021-04-30→ Common Stock, $.01 par value per share (50,000 underlying)
Footnotes (2)
- [F1]The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 25,000 on April 30, 2012, and 6,250 shares at the end of each successive three-month period until April 30, 2015, provided that the grantee remains employed by the Company on these dates.
- [F2]These options will become exercisable as follows: 12,500 on April 30, 2012, and 3,125 shares at the end of each successive three-month period until April 30, 2015, provided the optionee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001352961
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 1:08 PM ET
- Size
- 7.3 KB